Home » MHRA Develops Pilot With NICE, Offers Parallel Scientific Advice
MHRA Develops Pilot With NICE, Offers Parallel Scientific Advice
May 18, 2010
Manufacturers with drugs in clinical development will have an opportunity to obtain parallel advice from both the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute of Health and Clinical Excellence (NICE) under a pilot program launched last month.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor